Skip to main content
PeptiDex - Peptide Research and Education Platform
PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Research Disclaimer

All information on PeptiDex is for educational and research purposes only. None of the compounds discussed are FDA-approved for human consumption unless explicitly noted (e.g., Semaglutide under prescription). Always consult a qualified medical professional before considering any peptide protocol. The vendors listed operate as raw chemical and laboratory supply companies. Their products are intended solely for authorized laboratory, educational, and research purposes. PeptiDex does not sell, distribute, or endorse any compound for human or animal use.

PeptiDex

The independent, evidence-based peptide research index. Trusted by researchers worldwide.

Learn & Research

  • Peptide 101 Hub
  • Peptide Library
  • Evidence Dashboard
  • Research Blog
  • FAQ

Compare & Source

  • Vendor Reviews
  • Price Comparison
  • Compare Tool
  • Cycle Planner
  • Community Stacks

Recent Articles

  • Tesamorelin: What Sets It Apart from Every Other Growth Hormone Peptide
  • Peptide Stacking in 2026: Why Combination Protocols Are Redefining Results
  • The 2026 FDA Peptide Reclassification: What It Means for Patients, Providers, and the Future of Peptide Therapy

© 2026 PeptiDex. All rights reserved.

About UsEditorial PolicyMedical DisclaimerPrivacy & Terms
Home
Library
BlogStartToolsSaved
All Blends
🛡️

Thymosin Alpha-1 / BPC-157

"The Immune Fortress"

Thymosin Alpha-1BPC-157Immune Support

Benefits

Enhanced immunity, faster illness recovery, gut-immune axis support

Why This Blend?

Thymosin Alpha-1 supercharges immune cell function (T-cells, NK cells, dendritic cells), while BPC-157 heals the gut lining where 70% of the immune system resides. Attacking immune weakness from both sides.

Mechanism of Action

Tα1 enhances T-cell maturation, NK cell activity, and dendritic cell function for improved pathogen response. BPC-157 repairs gut mucosal integrity, supporting the gut-associated lymphoid tissue (GALT) — the body's largest immune organ.

Dosing Protocol

Typical Ratio: Thymosin Alpha-1 1.6mg + BPC-157 500mcg

Tα1 1.6mg SubQ 2x/week + BPC-157 250-500mcg SubQ daily. Cycle 8-24 weeks. Ideal during cold/flu season or post-illness.

Expected Timeline

Week 1

Immune activation; NK cell and T-cell enhancement begins

Weeks 2–4

Improved immune response; gut healing supports immune function

Months 2–3

Sustained immune modulation; reduced frequency of illness

Long-term

Long-term immune resilience; gut-immune axis restoration

Supporting Studies

Thymosin Alpha-1 safety and efficacy review

Review of 30+ clinical trials with 11,000+ subjects confirming safety and efficacy.

strong

BPC-157 gastrointestinal healing

BPC-157 heals GI ulcers and inflammatory bowel lesions.

preclinical

Safety Notes

Thymosin Alpha-1 approved in 35+ countries. Both peptides well-tolerated. Excellent safety profiles.

📚 Individual Peptide Profiles

Thymosin Alpha-1 →BPC-157 →